My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 217

    1.

    Association between CCR5 genotype and the clinical course of HIV-1 infection.

    de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, Bakker M, Roos MT, Prins M, de Wolf F, Coutinho RA, Miedema F, Goudsmit J, Schuitemaker H.

    Ann Intern Med. 1997 Nov 15;127(10):882-90.PMID: 9382366 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.

    Bratt G, Leandersson AC, Albert J, Sandström E, Wahren B.

    AIDS. 1998 May 7;12(7):729-36.PMID: 9619804 [PubMed - indexed for MEDLINE]Related articles

    3.

    HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.

    Walli R, Reinhart B, Luckow B, Lederer E, Loch O, Malo A, Wank R, Schlöndorff D, Goebel FD.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):229-33.PMID: 9665499 [PubMed - indexed for MEDLINE]Related articles

    4.

    Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.

    Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR, Benson EM, Carr A, Cooper DA, Kaldor JM.

    AIDS. 1997 Dec;11(15):1833-8.PMID: 9412701 [PubMed - indexed for MEDLINE]Related articles

    5.

    CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.

    de Roda Husman AM, Blaak H, Brouwer M, Schuitemaker H.

    J Immunol. 1999 Oct 15;163(8):4597-603.PMID: 10510404 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.

    Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ.

    AIDS. 2001 Jul 27;15(11):1343-52.PMID: 11504955 [PubMed - indexed for MEDLINE]Related articles

    7.

    Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

    Meyer L, Magierowska M, Hubert JB, Rouzioux C, Deveau C, Sanson F, Debre P, Delfraissy JF, Theodorou I.

    AIDS. 1997 Sep;11(11):F73-8.PMID: 9302436 [PubMed - indexed for MEDLINE]Related articles

    8.

    Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.

    Spijkerman IJ, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, Miedema F, de Wolf F.

    AIDS. 1997 Sep;11(11):1383-8.PMID: 9302449 [PubMed - indexed for MEDLINE]Related articles

    9.

    Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples.

    Blaak H, van't Wout AB, Brouwer M, Cornelissen M, Kootstra NA, Albrecht-van Lent N, Keet RP, Goudsmit J, Coutinho RA, Schuitemaker H.

    J Virol. 1998 Jan;72(1):218-24.PMID: 9420218 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.

    Buseyne F, Janvier G, Teglas JP, Ivanoff S, Burgard M, Bui E, Mayaux MJ, Blanche S, Rouzioux C, Rivière Y.

    J Infect Dis. 1998 Oct;178(4):1019-23.PMID: 9806029 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study.

    Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ.

    Ann Intern Med. 2000 Jun 20;132(12):959-63.PMID: 10858179 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.

    Cohen OJ, Vaccarezza M, Lam GK, Baird BF, Wildt K, Murphy PM, Zimmerman PA, Nutman TB, Fox CH, Hoover S, Adelsberger J, Baseler M, Arthos J, Davey RT Jr, Dewar RL, Metcalf J, Schwartzentruber DJ, Orenstein JM, Buchbinder S, Saah AJ, Detels R, Phair J, Rinaldo C, Margolick JB, Pantaleo G, Fauci AS.

    J Clin Invest. 1997 Sep 15;100(6):1581-9.PMID: 9294127 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Phenotypic expressions of CCR5-delta32/delta32 homozygosity.

    Nguyêñ GT, Carrington M, Beeler JA, Dean M, Aledort LM, Blatt PM, Cohen AR, DiMichele D, Eyster ME, Kessler CM, Konkle B, Leissinger C, Luban N, O'Brien SJ, Goedert JJ, O'Brien TR.

    J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):75-82.PMID: 10534150 [PubMed - indexed for MEDLINE]Related articles

    14.

    Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.

    Lathey JL, Tierney C, Chang SY, D'Aquila RT, Bettendorf DM, Alexander HC, Santini CD, Hughes AM, Barroga CF, Spector SA, Landes JE, Hammer SM, Katzenstein DA.

    J Infect Dis. 2001 Dec 1;184(11):1402-11. Epub 2001 Nov 13.PMID: 11709782 [PubMed - indexed for MEDLINE]Related articles

    15.

    Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.

    van Rij RP, de Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, Schuitemaker H.

    J Infect Dis. 1998 Dec;178(6):1806-11.PMID: 9815240 [PubMed - indexed for MEDLINE]Related articles

    16.

    Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.

    Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jakobsen PH, Gerstoft J.

    AIDS. 1996 Feb;10(2):167-73.PMID: 8838704 [PubMed - indexed for MEDLINE]Related articles

    17.

    Causal pathways for CCR5 genotype and HIV progression.

    Taylor JM, Wang Y, Ahdieh L, Chmiel JS, Detels R, Giorgi JV, Kaslow R, Kingsley L, Margolick J.

    J Acquir Immune Defic Syndr. 2000 Feb 1;23(2):160-71.PMID: 10737431 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.

    van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van't Wout AB, Schuitemaker H.

    AIDS. 2009 Jan 2;23(1):19-28.PMID: 19050382 [PubMed - indexed for MEDLINE]Related articles

    19.

    CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.

    Clegg AO, Ashton LJ, Biti RA, Badhwar P, Williamson P, Kaldor JM, Stewart GJ.

    AIDS. 2000 Jan 28;14(2):103-8.PMID: 10708279 [PubMed - indexed for MEDLINE]Related articles

    20.

    Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.

    Koot M, Keet IP, Vos AH, de Goede RE, Roos MT, Coutinho RA, Miedema F, Schellekens PT, Tersmette M.

    Ann Intern Med. 1993 May 1;118(9):681-8.PMID: 8096374 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity